Kallikrein Inhibitors (Toronto Innovation/Evotec)

Angiogenesis Inhibitors (Innovation Pharmaceuticals)

HLA-open conformer-specific monoclonal antibody

YQ23(New Beta Innovation Limited)

Captisol enabled furosemide (SQ Innovation)

Chimeric antigen receptor T-cell therapy (Hunan Zhaotai Yongren Biotech)

Monoclonal antibody CI-137(CSL Innovation)

Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate

C₅H₁₃O₇P

DN-201929

PMX-20005